{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T05:34:38Z","timestamp":1794980078802,"version":"4.9.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Natural Science Foundation of China for Young Scientists","award":["82400623"],"award-info":[{"award-number":["82400623"]}]},{"name":"Jiangsu Provincial Basic Research Program for Young Scientists","award":["BK20240489"],"award-info":[{"award-number":["BK20240489"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-05769-x","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T10:56:05Z","timestamp":1775559365000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The association between liver fibrosis markers and carotid atherosclerosis in non-alcoholic fatty liver disease is strongly influenced by age"],"prefix":"10.1186","volume":"26","author":[{"given":"Shuai","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"issue":"1","key":"5769_CR1","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s12944-025-02750-z","volume":"24","author":"J Zeng","year":"2025","unstructured":"Zeng J, Gu C, Wen C, et al. The burden of NAFLD (now referred to as MASLD)-related chronic liver disease and cirrhosis from 1990 to 2021 with projections to 2036: a comparative study of global China the United States and India. Lipids Health Dis. 2025;24(1):298. https:\/\/doi.org\/10.1186\/s12944-025-02750-z.","journal-title":"Lipids Health Dis"},{"issue":"6","key":"5769_CR2","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79(6):1542\u201356. https:\/\/doi.org\/10.1016\/j.jhep.2023.06.003.","journal-title":"J Hepatol"},{"issue":"6","key":"5769_CR3","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1161\/ATV.0000000000000153","volume":"42","author":"PB Duell","year":"2022","unstructured":"Duell PB, Welty FK, Miller M, et al. Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the American heart association. Arterioscler Thromb Vasc Biol. 2022;42(6):e168\u201385. https:\/\/doi.org\/10.1161\/ATV.0000000000000153.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"5769_CR4","doi-asserted-by":"publisher","first-page":"955","DOI":"10.14218\/JCTH.2024.00311","volume":"12","author":"JG Fan","year":"2024","unstructured":"Fan JG, Xu XY, Yang RX, et al. Guideline for the prevention and treatment of metabolic dysfunction-associated fatty liver disease (Version 2024). J Clin Transl Hepatol. 2024;12(11):955\u201374. https:\/\/doi.org\/10.14218\/JCTH.2024.00311.","journal-title":"J Clin Transl Hepatol"},{"issue":"3","key":"5769_CR5","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.3390\/ijms26031364","volume":"26","author":"V Tasouli-Drakou","year":"2025","unstructured":"Tasouli-Drakou V, Ogurek I, Shaikh T, et al. Atherosclerosis: a comprehensive review of molecular factors and mechanisms. Int J Mol Sci. 2025;26(3):1364. https:\/\/doi.org\/10.3390\/ijms26031364.","journal-title":"Int J Mol Sci"},{"issue":"20","key":"5769_CR6","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1097\/CM9.0000000000002839","volume":"136","author":"W Chen","year":"2023","unstructured":"Chen W, Li Z, Zhao Y, et al. Global and national burden of atherosclerosis from 1990 to 2019: trend analysis based on the global burden of disease study 2019. Chin Med J (Engl). 2023;136(20):2442\u201350. https:\/\/doi.org\/10.1097\/CM9.0000000000002839.","journal-title":"Chin Med J (Engl)"},{"issue":"2","key":"5769_CR7","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/liv.14669","volume":"41","author":"J Lee","year":"2021","unstructured":"Lee J, Vali Y, Boursier J, et al. Prognostic accuracy of FIB-4, NAFLD fibrosis score and APRI for NAFLD-related events: a systematic review. Liver Int. 2021;41(2):261\u201370. https:\/\/doi.org\/10.1111\/liv.14669.","journal-title":"Liver Int"},{"issue":"1","key":"5769_CR8","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12986-025-01039-3","volume":"22","author":"S Zhang","year":"2025","unstructured":"Zhang S, Liang H, Liu J, Zhu Y. The association between hepatic fibrosis indicators and subclinical carotid atherosclerosis in the population with metabolic dysfunction-associated steatotic liver disease under 50 years old. Nutr Metab (Lond). 2025;22(1):136. https:\/\/doi.org\/10.1186\/s12986-025-01039-3.","journal-title":"Nutr Metab (Lond)"},{"key":"5769_CR9","doi-asserted-by":"publisher","first-page":"1366015","DOI":"10.3389\/fendo.2024.1366015","volume":"15","author":"J Le\u00f3n-Meng\u00edbar","year":"2024","unstructured":"Le\u00f3n-Meng\u00edbar J, S\u00e1nchez E, Herrer\u00edas F, et al. Influence of nonalcoholic fatty liver disease severity on carotid adventitial vasa vasorum. Front Endocrinol (Lausanne). 2024;15:1366015. https:\/\/doi.org\/10.3389\/fendo.2024.1366015.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5769_CR10","doi-asserted-by":"publisher","first-page":"1651689","DOI":"10.3389\/fendo.2025.1651689","volume":"16","author":"J Le\u00f3n-Meng\u00edbar","year":"2026","unstructured":"Le\u00f3n-Meng\u00edbar J, Malag\u00f3n MM, Berm\u00fadez-L\u00f3pez M, et al. Association of estimated liver fibrosis with carotid but not femoral atherosclerotic burden: the ILERVAS cohort. Front Endocrinol (Lausanne). 2026;16:1651689. https:\/\/doi.org\/10.3389\/fendo.2025.1651689.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"5769_CR11","doi-asserted-by":"publisher","first-page":"e2351225","DOI":"10.1001\/jamanetworkopen.2023.51225","volume":"7","author":"J Fu","year":"2024","unstructured":"Fu J, Deng Y, Ma Y, et al. National and provincial-level prevalence and risk factors of carotid atherosclerosis in Chinese adults. JAMA Netw Open. 2024;7(1):e2351225. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.51225.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"5769_CR12","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1186\/s12877-025-06120-3","volume":"25","author":"S Zhang","year":"2025","unstructured":"Zhang S, Liang H, Liu J, et al. The association between inflammatory, metabolic, and hepatic fibrosis-related biomarkers and atrial fibrillation in older patients with metabolic dysfunction-associated steatotic liver disease. BMC Geriatr. 2025;25(1):459. https:\/\/doi.org\/10.1186\/s12877-025-06120-3.","journal-title":"BMC Geriatr"},{"issue":"8","key":"5769_CR13","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.3390\/molecules29081859","volume":"29","author":"S Zhang","year":"2024","unstructured":"Zhang S, Ren X, Zhang B, et al. A systematic review of statins for the treatment of nonalcoholic steatohepatitis: safety, efficacy, and mechanism of action. Molecules. 2024;29(8):1859. https:\/\/doi.org\/10.3390\/molecules29081859.","journal-title":"Molecules"},{"key":"5769_CR14","doi-asserted-by":"publisher","first-page":"3212795","DOI":"10.1155\/2024\/3212795","volume":"2024","author":"A Akbari","year":"2024","unstructured":"Akbari A, Hadizadeh S, Heidary L. Effects of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors on intima-media thickness: systematic review and meta-analysis. J Diabetes Res. 2024;2024:3212795. https:\/\/doi.org\/10.1155\/2024\/3212795.","journal-title":"J Diabetes Res"},{"issue":"3","key":"5769_CR15","doi-asserted-by":"publisher","first-page":"285","DOI":"10.21037\/qims.2016.05.03","volume":"6","author":"SS Ho","year":"2016","unstructured":"Ho SS. Current status of carotid ultrasound in atherosclerosis. Quant Imaging Med Surg. 2016;6(3):285\u201396. https:\/\/doi.org\/10.21037\/qims.2016.05.03.","journal-title":"Quant Imaging Med Surg"},{"key":"5769_CR16","doi-asserted-by":"publisher","unstructured":"Mathiesen EB, Johnsen SH. Ultrasonographic measurements of subclinical carotid atherosclerosis in prediction of ischemic stroke. Acta Neurol Scand Suppl. 2009;18968\u201372. https:\/\/doi.org\/10.1111\/j.1600-0404.2009.01210.x.","DOI":"10.1111\/j.1600-0404.2009.01210.x"},{"issue":"4","key":"5769_CR17","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/hep.21496","volume":"45","author":"P Angulo","year":"2007","unstructured":"Angulo P, Hui JM, Marchesini G, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007;45(4):846\u201354. https:\/\/doi.org\/10.1002\/hep.21496.","journal-title":"Hepatology"},{"issue":"10","key":"5769_CR18","doi-asserted-by":"publisher","first-page":"e0333490","DOI":"10.1371\/journal.pone.0333490","volume":"20","author":"V Mignot","year":"2025","unstructured":"Mignot V, Fabre O, Legrand R, et al. FIB-4: a screening tool for advanced liver fibrosis in a cohort of subjects participating in a primary care weight-loss program. PLoS ONE. 2025;20(10):e0333490. https:\/\/doi.org\/10.1371\/journal.pone.0333490.","journal-title":"PLoS ONE"},{"issue":"4","key":"5769_CR19","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/S1665-2681(19)31836-8","volume":"7","author":"A Loaeza-del-Castillo","year":"2008","unstructured":"Loaeza-del-Castillo A, Paz-Pineda F, Oviedo-C\u00e1rdenas E, et al. AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis. Ann Hepatol. 2008;7(4):350\u20137.","journal-title":"Ann Hepatol"},{"issue":"10","key":"5769_CR20","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.spinee.2021.02.024","volume":"21","author":"AJ Vickers","year":"2021","unstructured":"Vickers AJ, Holland F. Decision curve analysis to evaluate the clinical benefit of prediction models. Spine J. 2021;21(10):1643\u20138. https:\/\/doi.org\/10.1016\/j.spinee.2021.02.024.","journal-title":"Spine J"},{"issue":"1","key":"5769_CR21","doi-asserted-by":"publisher","first-page":"23334","DOI":"10.1038\/s41598-025-06871-4","volume":"15","author":"M Du","year":"2025","unstructured":"Du M, Li Y, Du J, et al. Association between liver fibrosis scores and cardiovascular disease in elderly based on NHANES 1999\u20132018. Sci Rep. 2025;15(1):23334. https:\/\/doi.org\/10.1038\/s41598-025-06871-4.","journal-title":"Sci Rep"},{"key":"5769_CR22","doi-asserted-by":"publisher","unstructured":"Xin Z, Zhu Y, Wang S et al. Associations of subclinical atherosclerosis with nonalcoholic fatty liver disease and fibrosis assessed by non-invasive score. Liver Int. 2020;40(4):806\u201314. https:\/\/doi.org\/10.1111\/liv.14322","DOI":"10.1111\/liv.14322"},{"issue":"1","key":"5769_CR23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12872-025-04491-4","volume":"25","author":"Y Miao","year":"2025","unstructured":"Miao Y, Wang Y, Wan Q, et al. The fibrosis-4 index and its association with carotid atherosclerosis in type 2 diabetes: a cross-sectional study in China. BMC Cardiovasc Disord. 2025;25(1):35. https:\/\/doi.org\/10.1186\/s12872-025-04491-4.","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"5769_CR24","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2337\/db13-1864","volume":"64","author":"NM Hanssen","year":"2015","unstructured":"Hanssen NM, Beulens JW, van Dieren S, et al. Plasma advanced glycation end products are associated with incident cardiovascular events in individuals with type 2 diabetes: a case-cohort study with a median follow-up of 10 years (EPIC-NL). Diabetes. 2015;64(1):257\u201365. https:\/\/doi.org\/10.2337\/db13-1864.","journal-title":"Diabetes"},{"issue":"1","key":"5769_CR25","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/s12933-024-02451-4","volume":"23","author":"FM Gutierrez-Mariscal","year":"2024","unstructured":"Gutierrez-Mariscal FM, Lopez-Moreno A, Torres-Pe\u00f1a JD, et al. Modulation of circulating levels of advanced glycation end products and its impact on intima-media thickness of both common carotid arteries: CORDIOPREV randomised controlled trial. Cardiovasc Diabetol. 2024;23(1):361. https:\/\/doi.org\/10.1186\/s12933-024-02451-4.","journal-title":"Cardiovasc Diabetol"},{"key":"5769_CR26","doi-asserted-by":"publisher","unstructured":"Morelli M, Tognola C, Garofani I et al. Association between carotid intima-media thickness and novel lipid parameters in hypertensive patients. High Blood Press Cardiovasc Prev. 2025;24. https:\/\/doi.org\/10.1007\/s40292-025-00718-9","DOI":"10.1007\/s40292-025-00718-9"},{"issue":"1","key":"5769_CR27","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","volume":"8","author":"S Chen","year":"2023","unstructured":"Chen S, Saeed AFUH, Liu Q, et al. Macrophages in immunoregulation and therapeutics. Signal Transduct Target Ther. 2023;8(1):207. https:\/\/doi.org\/10.1038\/s41392-023-01452-1.","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"5769_CR28","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1111\/liv.14595","volume":"40","author":"Z Xin","year":"2020","unstructured":"Xin Z, Zhu Y, Wang S, et al. Associations of subclinical atherosclerosis with nonalcoholic fatty liver disease and fibrosis assessed by non-invasive score. Liver Int. 2020;40(8):2043. https:\/\/doi.org\/10.1111\/liv.14595.","journal-title":"Liver Int"},{"key":"5769_CR29","doi-asserted-by":"publisher","first-page":"119161","DOI":"10.1016\/j.atherosclerosis.2025.119161","volume":"403","author":"SW Wang","year":"2025","unstructured":"Wang SW, Wang C, Cheng YM, et al. Liver and atherosclerotic risk of alcohol consumption in patients with metabolic dysfunction-associated steatotic liver disease. Atherosclerosis. 2025;403:119161. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.119161.","journal-title":"Atherosclerosis"},{"issue":"4","key":"5769_CR30","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1210\/clinem\/dgae619","volume":"110","author":"G Georgiopoulos","year":"2025","unstructured":"Georgiopoulos G, Athanasopoulos S, Mavraganis G, et al. Incremental value of blood-based markers of liver fibrosis in cardiovascular risk stratification. J Clin Endocrinol Metab. 2025;110(4):1115\u201327. https:\/\/doi.org\/10.1210\/clinem\/dgae619.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"5769_CR31","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.atherosclerosis.2015.05.002","volume":"241","author":"Y Chen","year":"2015","unstructured":"Chen Y, Xu M, Wang T, et al. Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease. Atherosclerosis. 2015;241(1):145\u201350. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.05.002.","journal-title":"Atherosclerosis"},{"issue":"2","key":"5769_CR32","doi-asserted-by":"publisher","first-page":"239","DOI":"10.5551\/jat.64809","volume":"32","author":"Y Kubotsu","year":"2025","unstructured":"Kubotsu Y, Sakamoto Y, Tago M, et al. FIB-4 index and liver stiffness measurement are potential predictors of atherosclerosis in metabolic dysfunction-associated steatotic liver disease. J Atheroscler Thromb. 2025;32(2):239\u201352. https:\/\/doi.org\/10.5551\/jat.64809.","journal-title":"J Atheroscler Thromb"},{"issue":"1","key":"5769_CR33","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12933-020-01064-x","volume":"19","author":"HH Lee","year":"2020","unstructured":"Lee HH, Cho Y, Choi YJ, et al. Non-alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: a Korean cohort study. Cardiovasc Diabetol. 2020;19(1):81. https:\/\/doi.org\/10.1186\/s12933-020-01064-x.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"5769_CR34","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12986-025-00951-y","volume":"22","author":"H Zhang","year":"2025","unstructured":"Zhang H, Lin F, Miao M, et al. Liver fibrosis increases the risk of subclinical atherosclerosis in patients with MASLD: a cross-sectional and longitudinal study. Nutr Metab (Lond). 2025;22(1):68. https:\/\/doi.org\/10.1186\/s12986-025-00951-y.","journal-title":"Nutr Metab (Lond)"},{"issue":"10","key":"5769_CR35","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/GME.0000000000001829","volume":"28","author":"M Wang","year":"2021","unstructured":"Wang M, Kartsonaki C, Guo Y, et al. Factors related to age at natural menopause in China: results from the China Kadoorie Biobank. Menopause. 2021;28(10):1130\u201342. https:\/\/doi.org\/10.1097\/GME.0000000000001829.","journal-title":"Menopause"},{"issue":"2","key":"5769_CR36","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1124\/jpet.111.183798","volume":"339","author":"O Lekontseva","year":"2011","unstructured":"Lekontseva O, Chakrabarti S, Jiang Y, et al. Role of neuronal nitric-oxide synthase in estrogen-induced relaxation in rat resistance arteries. J Pharmacol Exp Ther. 2011;339(2):367\u201375. https:\/\/doi.org\/10.1124\/jpet.111.183798.","journal-title":"J Pharmacol Exp Ther"},{"key":"5769_CR37","doi-asserted-by":"publisher","first-page":"5523516","DOI":"10.1155\/2021\/5523516","volume":"2021","author":"D Xiang","year":"2021","unstructured":"Xiang D, Liu Y, Zhou S, et al. Protective effects of estrogen on cardiovascular disease mediated by oxidative stress. Oxid Med Cell Longev. 2021;2021:5523516. https:\/\/doi.org\/10.1155\/2021\/5523516.","journal-title":"Oxid Med Cell Longev"},{"issue":"15","key":"5769_CR38","doi-asserted-by":"publisher","first-page":"e70877","DOI":"10.1096\/fj.202500244RRR","volume":"39","author":"Y Xin","year":"2025","unstructured":"Xin Y, Yuan Z, Wang J, Li S. Complex interplay between estrogen and aging via lipid metabolism and inflammation forms the novel treatment strategies for atherosclerosis. FASEB J. 2025;39(15):e70877. https:\/\/doi.org\/10.1096\/fj.202500244RRR.","journal-title":"FASEB J"},{"issue":"2","key":"5769_CR39","doi-asserted-by":"publisher","first-page":"740","DOI":"10.3390\/jcm15020740","volume":"15","author":"A Szeliga","year":"2026","unstructured":"Szeliga A, Chedraui P, Meczekalski B. The impact of the menopausal transition on body composition and abdominal fat redistribution. J Clin Med. 2026;15(2):740. https:\/\/doi.org\/10.3390\/jcm15020740.","journal-title":"J Clin Med"},{"key":"5769_CR40","doi-asserted-by":"publisher","unstructured":"Leivas G, Maraschin CK, Blume CA et al. Accuracy of ultrasound diagnosis of nonalcoholic fatty liver disease in patients with classes II and III obesity: a pathological image study. Obes Res Clin Pract. 2021;15(5):461\u20135. https:\/\/doi.org\/10.1016\/j.orcp.2021.09.002.","DOI":"10.1016\/j.orcp.2021.09.002"},{"issue":"5","key":"5769_CR41","doi-asserted-by":"publisher","first-page":"e1135","DOI":"10.1016\/j.cgh.2021.06.042","volume":"20","author":"W Sohn","year":"2022","unstructured":"Sohn W, Kwon HJ, Chang Y, et al. Liver fibrosis in asians with metabolic dysfunction-associated fatty liver disease. Clin Gastroenterol Hepatol. 2022;20(5):e1135\u201348. https:\/\/doi.org\/10.1016\/j.cgh.2021.06.042.","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-05769-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05769-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05769-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T22:50:11Z","timestamp":1779403811000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-05769-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5769"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-05769-x","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"29 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The portions of this study involving human participants, human materials, or human data were conducted in accordance with the Declaration of Helsinki.The study has been approved by the Ethics Committee of Northern Jiangsu People\u2019s Hospital (Approval Number: 2024ky342). These studies were conducted in accordance with local legislation and institutional requirements. Due to the retrospective nature of this study, the ethics committee\/institutional review board waived the requirement for written informed consent from the participants or their legal guardians\/next of kin.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"424"}}